Farrell A. Tobolowsky

Infectious Disease

5673 Peachtree Dunwoody Road
Ste600
Atlanta, GA 30342

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Direct Hospitalization Costs Associated with Resistant and Susceptible Salmonella and Shigella Infections in the United States, 2012-2019.

Direct Hospitalization Costs Associated with Resistant and Susceptible Salmonella and Shigella Infections in the United States, 2012-2019.

Journal: Foodborne pathogens and disease

Published: August 17, 2026

Immunogenicity of type 2 novel oral poliovirus vaccine administered in outbreak response, Kenya 2023: an observational cohort study.

Immunogenicity of type 2 novel oral poliovirus vaccine administered in outbreak response, Kenya 2023: an observational cohort study.

Journal: Vaccine

Published: May 19, 2026

Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Child with No Known Exposure - San Francisco, California, December 2024-January 2025.

Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Child with No Known Exposure - San Francisco, California, December 2024-January 2025.

Journal: MMWR. Morbidity and mortality weekly report

Published: September 04, 2025

Human infections with highly pathogenic avian influenza A(H5N1) viruses in the United States from March 2024 to May 2025.

Human infections with highly pathogenic avian influenza A(H5N1) viruses in the United States from March 2024 to May 2025.

Journal: Nature medicine

Published: May 22, 2025

Notes from the Field: Rhodesiense Human African Trypanosomiasis (Sleeping Sickness) in a Traveler Returning from Zimbabwe - United States, August 2024.

Notes from the Field: Rhodesiense Human African Trypanosomiasis (Sleeping Sickness) in a Traveler Returning from Zimbabwe - United States, August 2024.

Journal: MMWR. Morbidity and mortality weekly report

Published: March 20, 2025

Safety of nOPV2 administered during a supplementary immunisation activity in Uganda, 2022: data triangulation from a prospective cohort event monitoring programme and vaccine safety surveillance reports.

Safety of nOPV2 administered during a supplementary immunisation activity in Uganda, 2022: data triangulation from a prospective cohort event monitoring programme and vaccine safety surveillance reports.

Journal: The Lancet. Global health

Published: June 12, 2024

Novel Oral Poliovirus Vaccine 2 Safety Evaluation during Nationwide Supplemental Immunization Activity, Uganda, 2022.

Novel Oral Poliovirus Vaccine 2 Safety Evaluation during Nationwide Supplemental Immunization Activity, Uganda, 2022.

Journal: Emerging infectious diseases

Published: March 25, 2024

Update on Wild Poliovirus Type 1 Outbreak - Southeastern Africa, 2021-2022.

Update on Wild Poliovirus Type 1 Outbreak - Southeastern Africa, 2021-2022.

Journal: MMWR. Morbidity and mortality weekly report

Published: April 13, 2023

Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol - United States, May-August 2022.

Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol - United States, May-August 2022.

Journal: MMWR. Morbidity and mortality weekly report

Published: September 15, 2022

Notes from the Field: Wound Botulism Outbreak Among a Group of Persons Who Inject Drugs - Dallas, Texas, 2020.

Notes from the Field: Wound Botulism Outbreak Among a Group of Persons Who Inject Drugs - Dallas, Texas, 2020.

Journal: MMWR. Morbidity and mortality weekly report

Published: April 14, 2022

Fourteen mcr-1-Positive Salmonella enterica Isolates Recovered from Travelers Returning to the United States from the Dominican Republic.

Fourteen mcr-1-Positive Salmonella enterica Isolates Recovered from Travelers Returning to the United States from the Dominican Republic.

Journal: Microbiology resource announcements

Published: April 13, 2022

Longitudinal serologic and viral testing post-SARS-CoV-2 infection and post-receipt of mRNA COVID-19 vaccine in a nursing home cohort-Georgia, October 2020‒April 2021.

Longitudinal serologic and viral testing post-SARS-CoV-2 infection and post-receipt of mRNA COVID-19 vaccine in a nursing home cohort-Georgia, October 2020‒April 2021.

Journal: PloS one

Published: January 31, 2022

Showing 1-12 of 32

Last Updated: 09/26/2026